Defined Marketing And Labelling Of CBD Remains On Hold While FDA Determines Regulatory Path
Several high-profile lawsuits challenging the legal status of CBD products have been stayed (effectively put on ice until the FDA outlines a regulatory path forward for CBD in foods and supplements) or voluntarily dismissed in recent weeks.
Many judges took the stance that primary jurisdiction’s rule will apply, and it would be better if courts didn’t make local determinations. Meanwhile, the FDA is working on a regulatory path for ingestible CBD products. However, the FDA has not taken any official stance. Due to this, many cases will be stayed until the FDA reaches a conclusion regarding marketing and labelling of CBD products.
CBD brands are stuck in a limbo, surrounded by legalities. Some support the idea that brands have only themselves to blame if they went into the market before the regulations were set up. On the other hand, the FDA’s warning letters to companies making unestablished claims is sending mixed signals and is the cause of a lot of confusions. With a global pandemic going on, CBD might not be a priority for the FDA. With the prices for hemp falling drastically, the US Hemp Roundtable had to request the USDA to make hemp farmers qualify for government support.
Read Full Article: https://www.foodnavigator-usa.com
CBD is one of many powerful cannabinoids found in hemp known for helping to support our body and mind. Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. The FDA has not confirmed that CBD cures, treats, or prevents any diseases or conditions. Before reading this article please take a moment to read our full disclosure statement.